These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8785938)

  • 21. Preface: Congress on Alternative Test Methods in Inhalation Toxicology.
    Hensel A
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):99. PubMed ID: 18499417
    [No Abstract]   [Full Text] [Related]  

  • 22. General information about the study on the evaluation of the relevance of the target animal safety test (TAST).
    Altern Lab Anim; 2002; 30(5):489-91. PubMed ID: 12434772
    [No Abstract]   [Full Text] [Related]  

  • 23. Is there an alternative?
    Farrant A
    Nurs Stand; 2003 Jul 2-8; 17(42):18-9. PubMed ID: 12874922
    [No Abstract]   [Full Text] [Related]  

  • 24. Integrated decision-tree testing strategies for skin corrosion and irritation with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():65-74. PubMed ID: 19025332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in applying the three Rs of Russell & Burch to the testing of biological products.
    Balls M; Halder M
    Dev Biol (Basel); 2002; 111():3-13. PubMed ID: 12678219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three Rs Approaches in Marine Biotoxin Testing. The Report and Recommendations of a joint ECVAM/DG SANCO Workshop (ECVAM Workshop 54).
    Hess P; Grune B; Anderson DB; Aune T; Botana LM; Caricato P; van Egmond HP; Halder M; Hall S; Lawrence JF; Moffat C; Poletti R; Richmond J; Rossini GP; Seamer C; Vilageliu JS;
    Altern Lab Anim; 2006 May; 34(2):193-224. PubMed ID: 16704292
    [No Abstract]   [Full Text] [Related]  

  • 27. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation.
    Höfer T; Gerner I; Gundert-Remy U; Liebsch M; Schulte A; Spielmann H; Vogel R; Wettig K
    Arch Toxicol; 2004 Oct; 78(10):549-64. PubMed ID: 15170526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progress in the replacement of animal experiments in the quality control of clostridial vaccines].
    Cussler K; Borrmann E; Werner E
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):172-7. PubMed ID: 11998369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developments in pertussis vaccines leading to reduction and replacement of in vivo testing.
    Redhead K
    Dev Biol Stand; 1996; 86():263-70. PubMed ID: 8785955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory requirements for veterinary vaccine stability in the European Community.
    Fawthrop D
    Dev Biol Stand; 1996; 87():319-27. PubMed ID: 8854032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin.
    Borrmann E; Schulze F; Cussler K; Hänel I; Diller R
    Vet Microbiol; 2006 Apr; 114(1-2):41-50. PubMed ID: 16361070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Seventh Amendment directive--an unnecessary measure to a necessary end--possible legal challenges to directive 2003/15/EC of the European Parliament and of the Council Amending Council Directive 76/768/EEC under European Union law.
    Rosholt AP
    Food Drug Law J; 2005; 60(3):421-46. PubMed ID: 16304747
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of a monoclonal antibody for in vitro potency testing of erysipelas bacterins.
    Henderson LM; Jenkins PS; Scheevel KF; Walden DM
    Dev Biol Stand; 1996; 86():334. PubMed ID: 8785974
    [No Abstract]   [Full Text] [Related]  

  • 34. Alternatives to animals in the development and control of biological products for human and veterinary use. The role of the European Pharmacopoeia.
    Artiges A
    Dev Biol Stand; 1999; 101():29-35. PubMed ID: 10566772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consistency as tool to support in vitro batch potency testing in GMP production.
    Stirling C
    Dev Biol (Basel); 2012; 134():115-8. PubMed ID: 22888603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 4R concept for the safety testing of immunobiologicals.
    Cussler K
    Dev Biol Stand; 1999; 101():121-6. PubMed ID: 10566784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of protective erysipelas antibodies in pig and mouse sera as possible alternatives to the animal challenge models currently used for potency tests.
    Beckmann R; Gyra H; Cussler K
    Dev Biol Stand; 1996; 86():326. PubMed ID: 8785966
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of alternatives to animal tests in developing countries.
    Hong HA; Hendriks J
    Dev Biol Stand; 1999; 101():209-14. PubMed ID: 10566795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The validation of potency tests: hurdles identified by EMA/CVMP/IWP.
    Woodland R
    Dev Biol (Basel); 2012; 134():69-73. PubMed ID: 22888597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay.
    Aggerbeck H; Heron I
    Dev Biol Stand; 1996; 86():297-301. PubMed ID: 8785958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.